analyst
EX
NASDAQ · EXEL
Exelixis, Inc.
Healthcare · Biotechnology
$59.02
Up+$1.31 (+2.22%)
Updated Oct 9, 2026, 7:11 PM
SID Score
7.0/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 11.1B
- P/E ratio
- 16.39
- Dividend yield
- 0.00%
- 52-week range
- $33.76 – $61.14
- Volume
- 2.68M
- Avg. volume
- 2.76M
Price performance · EXEL
EXEL price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 8, 2026
EXEL closed at $59.02 after 21 trading sessions, up 2.77% for the selected period.
- Last close
- $59.02
- Period change
- +2.77%
- Period low
- $56.12
- Period high
- $59.02
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 8, 2026 | $58.07 | $60.08 | $57.91 | $59.02 | 2.68M |
| Oct 7, 2026 | $58.47 | $59.265 | $57.88 | $58.44 | 2.37M |
| Oct 6, 2026 | $58.85 | $59.00 | $57.02 | $58.33 | 2.03M |
| Oct 5, 2026 | $58.36 | $59.79 | $57.815 | $58.85 | 2.58M |
| Oct 2, 2026 | $58.11 | $58.97 | $57.94 | $58.39 | 1.97M |
| Oct 1, 2026 | $58.54 | $59.28 | $57.76 | $57.94 | 1.37M |
| Sep 30, 2026 | $58.90 | $61.14 | $58.40 | $58.41 | 3.07M |
| Sep 29, 2026 | $58.06 | $59.125 | $57.53 | $58.65 | 2.24M |
| Sep 28, 2026 | $57.97 | $58.66 | $57.51 | $58.37 | 1.28M |
| Sep 25, 2026 | $58.25 | $58.62 | $57.63 | $58.16 | 1.99M |
| Sep 24, 2026 | $56.70 | $57.99 | $56.58 | $57.95 | 1.93M |
| Sep 23, 2026 | $58.22 | $58.66 | $56.26 | $56.73 | 1.43M |
| Sep 22, 2026 | $57.65 | $59.0895 | $57.33 | $58.15 | 1.86M |
| Sep 21, 2026 | $58.61 | $58.805 | $56.9009 | $57.22 | 2.1M |
| Sep 18, 2026 | $58.285 | $59.15 | $57.895 | $58.36 | 5.24M |
| Sep 17, 2026 | $57.23 | $58.52 | $57.23 | $58.49 | 1.79M |
| Sep 16, 2026 | $57.04 | $57.78 | $56.325 | $56.78 | 1.88M |
| Sep 15, 2026 | $55.93 | $56.97 | $54.945 | $56.90 | 1.98M |
| Sep 14, 2026 | $56.44 | $57.07 | $55.91 | $56.21 | 1.74M |
| Sep 11, 2026 | $56.76 | $57.43 | $54.545 | $56.12 | 2.92M |
| Sep 10, 2026 | $58.33 | $58.33 | $57.23 | $57.43 | 1.79M |
Latest EXEL news
The latest Smart Investors Daily articles mentioning EXEL.
Stock researchMarket Activity · Institutional Ownership
Company
Market Activity
Research & News
Loading stock research…

